Patients' race/ethnicity and sex may have an effect on prescribing patterns for opioid and nonopioid medications.
Non-research industry payments to physicians may be associated with increases in opioid prescribing rates.
Implementing medical or adult-use marijuana laws may reduce the rate of opioid prescribing for Medicaid enrollees.
Individuals with and without cancer may be affected in a similar manner by concerns surrounding opioids that have led to reductions in their prescribing.
Opioid prescribing trends in the Veterans Health Administration from 2010 to 2016 followed similar trajectories as non-VHA settings, peaking around 2012 then declining.
Prescription opioid duration — not dosage — following surgery may be associated with a greater risk for opioid misuse in patients with no prior history of opioid use.
Implementation of electronic medical record default opioid prescriptions of 10 tablets of 5 mg oxycodone/325 mg acetaminophen at discharge from the ED may be associated with an increased percentage of prescriptions for 10 tablets, compared with no default.
Opioids may be overprescribed frequently after surgery in most specialties.
Among disabled Medicare beneficiaries, county-level socioeconomic factors are associated with opioid prescriptions, with more prescriptions seen with lower socioeconomic indicators.
Patient education and information gathering are important initial approaches to managing concerning behaviors such as missing appointments or taking more opioid medication than prescribed.
Patients used only 40% of the hydrocodone-acetaminophen combination tablets prescribed to them following rhinoplasty.
The Joint Commission has provided insight into trends in opioid prescriptions over the last 3 decades, as well as current quality and safety problems in acute pain management.
Gynecologists prescribe about twice the amount of opioids than patients use after hysterectomy for benign, nonobstetric indications.
Although the registration to prescription drug monitoring programs (PDMPs) was shown to lead to statewide declines in high-risk opioid prescriptions, these declines were similar to those observed in non-PDMP registrants.
Dr Zacharoff provided advice for clinicians dealing with fluid guidelines and constraints regarding opioid prescribing.
More than half of all opioids prescribed in the United States are for patients who have a mental health disorder.
Longitudinal opioid prescribing patterns suggest that regular use among patients with rheumatoid arthritis (RA) is slightly declining.
The majority of PA students and practicing PAs did not feel that their PA program adequately trained them to screen for opioid abuse.
Concurrent benzodiazepine and opioid use increased by 80% between 2001 and 2013 in the United States and significantly contributes to the overall population risk of opioid overdose.
Doctors who limit the supply of opioids they prescribe to 3 days or less may help patients reduce their risk of dependence and addiction.
Researchers reviewed studies that examined the role of emergency department doctors in the US opioid epidemic.
A training program on opioid prescribing for general practice registrars was developed to improve adherence to guidelines on opioid prescribing for chronic noncancer pain.
Anthony Mariano, PhD, provided guidance for clinicians for tapering patients off opioids.
The American Society of Interventional Pain Physicians (ASIPP) has issued updated opioid prescribing guidelines for the management of patients with chronic, non-cancer pain.
Throughout 2016, the FDA has announced requirements for manufacturers to create new product labeling information for a variety of opioid medications.
Limited information has been published on institutional determinants of prescribing opioids and their possible relationship to the opioid epidemic.
A high level of comorbidity exists between substance use disorders and chronic pain.
Clinical Pain Advisor Articles
- Supervised Injection Sites: Facts, Information, Pros, and Cons
- Chronic Pain May Be a Contributing Factor to Suicide
- Striking a Balance Between Opioid Surveillance and Patient Privacy
- Demographic Characteristics of Pregnant Women With Opioid Use Disorder
- Effects of Mindfulness Therapy, Pharmacologic Prophylaxis on Catecholamine Levels in Migraine
- Perioperative Pain Management in Patients With Opioid Use Disorder
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Reviewing the Efficacy of Invasive Procedures for Chronic Back, Knee Pain
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Lower Weighting of Hand Cortical Representations in CRPS
- Predicting Success of Focal Nerve Surgery Based on Diagnostic Block Response
- Aetna-CVS Merger Approved
- FDA Announces Draft Guidance for Consumer OTC Access to Previously Prescription Drugs
- Maryland Legislature: Will Federal Courts Permit State Regulation of Drug Prices?